Enzon Pharmaceuticals (ENZN) Stock Price & Overview
NASDAQ:ENZN
Current stock price
The current stock price of ENZN is 0.46 null. Today ENZN is up by 2.22%. In the past month the price decreased by -8%. In the past year, price decreased by -62.3%.
ENZN Key Statistics
- Market Cap
- 20.341M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.05
- Dividend Yield
- 38.46%
ENZN Stock Performance
ENZN Stock Chart
ENZN Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ENZN. When comparing the yearly performance of all stocks, ENZN is a bad performer in the overall market: 90.51% of all stocks are doing better.
ENZN Earnings
ENZN Forecast & Estimates
ENZN Financial Highlights
Over the last trailing twelve months ENZN reported a non-GAAP Earnings per Share(EPS) of -0.05.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 100.07% | ||
| ROA | -12.28% | ||
| ROE | -12.58% | ||
| Debt/Equity | 0 |
ENZN Ownership
About ENZN
Company Profile
Enzon Pharmaceuticals, Inc. is a biotechnology company. It discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company's marketed drug products include PegIntron (R) for chronic hepatitis C; Sylatron (R) for Melanoma; Macugen (R) for neovascular age-related macular degeneration; CIMZIA (R) for Crohn's disease; Oncaspar for acute lymphoblastic leukemia; and Adagen for severe combined immunedeficiency. Enzon Pharmaceuticals, Inc. is headquartered in Piscataway, New Jersey.
Company Info
Enzon Pharmaceuticals
20 Commerce Drive Suite 135
Cranford NJ 07016
CEO: Andrew Rackear
Phone: 732-980-4500
Enzon Pharmaceuticals / ENZN FAQ
What does ENZN do?
Enzon Pharmaceuticals, Inc. is a biotechnology company. It discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company's marketed drug products include PegIntron (R) for chronic hepatitis C; Sylatron (R) for Melanoma; Macugen (R) for neovascular age-related macular degeneration; CIMZIA (R) for Crohn's disease; Oncaspar for acute lymphoblastic leukemia; and Adagen for severe combined immunedeficiency. Enzon Pharmaceuticals, Inc. is headquartered in Piscataway, New Jersey.
What is the stock price of Enzon Pharmaceuticals today?
The current stock price of ENZN is 0.46 null. The price increased by 2.22% in the last trading session.
What is the dividend status of Enzon Pharmaceuticals?
Enzon Pharmaceuticals (ENZN) has a dividend yield of 38.46%. The yearly dividend amount is currently 0.15.
What is the ChartMill rating of Enzon Pharmaceuticals stock?
ENZN has a ChartMill Technical rating of 0 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
Can you provide the ownership details for ENZN stock?
You can find the ownership structure of Enzon Pharmaceuticals (ENZN) on the Ownership tab.